Author: Matt Portnoy
Before transferring to the NIH Office of the Director, Office of Extramural Research, in February 2011, Matt was responsible for grants related to DNA repair and recombination and also coordinated SBIR and STTR small business grants for NIGMS.
Posts by Matt Portnoy
NIGMS (and other NIH) investigators previously have been able to obtain over 2,500 knockout mouse strains at a negotiated cost from Lexicon. These mouse strains are no longer available directly through Lexicon.
You may now request them, along with an additional 1,000 knockout strains, through Taconic. NIH investigators acquiring a Lexicon knockout mouse through Taconic are expected to place the mouse lines in a NIH-supported mouse repository.
The NIH Guide notice updates the policy and provides more details.
NIH has announced two new, technology-oriented Recovery Act funding opportunities targeted to businesses:
- The Small Business Catalyst Awards for Accelerating Innovative Research (R43) will speed innovation by supporting early-stage ideas with commercial potential that promise to greatly advance a technological area within the NIH mission—not merely lead to incremental improvements of existing technologies. NIH plans to award 20 to 25 one-year grants, each up to $200,000 in total costs. Applications from small businesses with no prior NIH Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) support may receive funding priority.
If you’re interested in applying for either opportunity, send your letters of intent by August 3, 2009. Please feel free to contact me offline with specific questions.
